Staged versus one-time complete revascularization with percutaneous coronary intervention for multivessel coronary artery disease patients without ST-elevation myocardial infarction

Circulation: Cardiovascular Interventions

Volumn 6, Issue 1, 2013, Pages 12-20

  Hannan, Edward L ^a,i   Samadashvili, Zaza ^a   Walford, Gary ^b   Jacobs, Alice K ^c   Stamato, Nicholas J ^d   Venditti, Ferdinand J ^e   Holmes, David R ^f   Sharma, Samin ^g   King III, Spencer B ^h  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c BOSTON MEDICAL CENTER   (United States)

^d United Health Services   (United States)

^e ALBANY MEDICAL CENTER   (United States)

^f MAYO CLINIC   (United States)

^g MOUNT SINAI MEDICAL CENTER   (United States)

^h St Joseph's Health System   (United States)

ⁱ UNIVERSITY AT ALBANY   (United States)

Author keywords

Complete revascularization; Multivessel disease; PCI; Staging

Indexed keywords

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; CORONARY RISK; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RISK ASSESSMENT; UNSTABLE ANGINA PECTORIS;

EID: 84879138927     PISSN: 19417640     EISSN: 19417632     Source Type: Journal    
DOI: 10.1161/CIRCINTERVENTIONS.112.974485     Document Type: Article

References (16)

1. Kornowski R, Mehran R, Dangas G, Nikolsky E, Assali A, Claessen BE, Gersh BJ, Wong SC, Witzenbichler B, Guagliumi G, Dudek D, Fahy M, Lansky AJ, Stone GW; HORIZONS-AMI Trial Investigators. Prognostic impact of staged versus "one-time" multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial. J Am Coll Cardiol. 2011;58:704-711.
2. Vlaar PJ, Mahmoud KD, Holmes DR, Jr, van Valkenhoef G, Hillege HL, van der Horst IC, Zijlstra F, de Smet BJ. Culprit vessel only versus multivessel and staged percutaneous coronary intervention for multivessel disease in patients presenting with ST-segment elevation myocardial infarction: a pairwise and network meta-analysis. J Am Coll Cardiol. 2011;58:692-703.
3. Hannan EL, Samadashvili Z, Walford G, Holmes DR, Jr, Jacobs AK, Stamato NJ, Venditti FJ, Sharma S, King SB 3rd. Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease. J Am Coll Cardiol Cardiovasc Interv. 2010;3:22-31.
4. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC, Jr, Alpert JS, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK; American College of Cardiology; American Heart Association Task Force on Practice Guidelines; Canadian Cardiovascular Society. ACC/AHA guidelines for the management of patients with STelevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation. 2004;110:e82-292.
5. Antman EM, Hand M, Armstrong PW, Bates ER, Green LA, Halasyamani LK, Hochman JS, Krumholz HM, Lamas GA, Mullany CJ, Pearle DL, Sloan MA, Smith SC Jr, Anbe DT, Kushner FG, Ornato JP, Jacobs AK, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Halperin JL, Hunt SA, Lytle BW, Nishimura R, Page RL, Riegel B, Tarkington LG, Yancy CW. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with acute myocardial infarction. J Am Coll Cardiol. 2008; 51:210-247.
6. Bundled payments for care improvement. http://www.innovations.cms.gov/ initiatives/bundled-payments/index.html on 04/02/12. Accessed January 4, 2013.
7. Rosenbaum PR. Observational Studies. New York, NY: Springer-Verlag; 1995.
8. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70:41-55.
9. Rosenbaum PR. Optimal matching for observational studies. JASA. 1989;84: 41-55.
10. Gu XS, Rosenbaum PR. Comparison of multivariate matching methods, structures, differences, and algorithms. J Comput Graph Stat. 1993;2:405-420.
11. Austin PC, Grootendorst P, Anderson GM. A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study. Stat Med. 2007;26:734-753.
12. Wu C, Dyer AM, King SB, III, Walford G, Holmes DR Jr, Stamato NJ, Venditti FJ, Sharma SK, Fergus I, Jacobs AK, Hannan EL. Impact of incomplete revascularization on long-term mortality after coronary stenting. Circ Cardiovasc Interv. 2011;4:413-421.
13. Holford TH. Multivariate Methods in Epidemiology. New York, NY: Oxford Press; 2002.
14. Hannan EL, Wu C, Walford G, Holmes DR, Jones RH, Sharma S, King SB, III. Incomplete revascularization in the era of drug-eluting stents: impact on adverse outcomes. J Am Coll Cardiol Cardiovasc Interv. 2009;2:17-25.
15. Dangas GD, George JC, Weintraub W, Popma JJ. Timing of staged percutaneous coronary intervention in multivessel coronary artery disease. J Am Coll Cardiol Cardiovasc Interv. 2010;3:1096-1099.
16. Blankenship JC, Moussa ID, Chambers CC, Brilakis ES, Haldis TA, Morrison DA, Dehmer GJ; Society for Cardiovascular Angiography and Interventions. Staging of multivessel percutaneous coronary interventions: an expert consensus statement from the Society for Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv. 2012;79:1138-1152.